Verrica Pharmaceuticals (VRCA) Inventory Average (2023 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Inventory Average of $2.1 million for Q1 2026, down 14.47% year-over-year from $2.5 million in Q1 2025, and down 7.27% quarter-over-quarter from $2.3 million in Q4 2025.
Verrica Pharmaceuticals (VRCA) Inventory Average (2023 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Inventory Average history runs 4 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Inventory Average fell 14.47% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 14.47% YoY), while the FY2025 annual figure was $2.3 million, up 34.84% from the prior year.
- Inventory Average for Q1 2026 stood at $2.1 million, down from $2.3 million in the prior quarter.
- The five-year high for Inventory Average was $2.6 million in Q3 2024, with the low at $650500.0 in Q4 2023.
- The 4-year median for Inventory Average is $2.4 million (2025), against an average of $2.2 million.
- The sharpest annual moves came in 2024 and 2026: Inventory Average soared 287.93% in 2024, then declined 14.47% in 2026.
- Verrica Pharmaceuticals' Inventory Average stood at $650500.0 in 2023, then jumped by 287.93% to $2.5 million in 2024, then dropped by 10.05% to $2.3 million in 2025, then fell by 7.27% to $2.1 million in 2026.
- Business Quant data shows VRCA's Inventory Average at $2.1 million in Q1 2026, $2.3 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | - |
| 10 | Verrica Pharmaceuticals | 100.99 Mn | 89.79 Mn | - | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Mn |
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.46 Mn |
| Dec 31, 2024 | 2.52 Mn |
| Sep 30, 2024 | 2.64 Mn |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 650,500.00 |